Presentation is loading. Please wait.

Presentation is loading. Please wait.

Severe hypoglycemia after initiation of anti–tumor necrosis factor therapy with etanercept in a patient with generalized pustular psoriasis and type 2.

Similar presentations


Presentation on theme: "Severe hypoglycemia after initiation of anti–tumor necrosis factor therapy with etanercept in a patient with generalized pustular psoriasis and type 2."— Presentation transcript:

1 Severe hypoglycemia after initiation of anti–tumor necrosis factor therapy with etanercept in a patient with generalized pustular psoriasis and type 2 diabetes mellitus  Carlos G. Wambier, MD, Maria C. Foss-Freitas, MD, PhD, Renato S. Paschoal, MD, Marilia V. Tomazini, MD, João C. Simão, MD, Milton C. Foss, MD, PhD, Norma T. Foss, MD, PhD  Journal of the American Academy of Dermatology  Volume 60, Issue 5, Pages (May 2009) DOI: /j.jaad Copyright © 2008 American Academy of Dermatology, Inc. Terms and Conditions

2 Fig 1 Capillary blood glucose measurements from the hospitalization days 28 to 46. Note the need for several intravenous infusions of hypertonic glucose to maintain adequate blood glucose levels. Adequate glycemic control was obtained during the last week of hospitalization even though insulin therapy was discontinued. Journal of the American Academy of Dermatology  , DOI: ( /j.jaad ) Copyright © 2008 American Academy of Dermatology, Inc. Terms and Conditions


Download ppt "Severe hypoglycemia after initiation of anti–tumor necrosis factor therapy with etanercept in a patient with generalized pustular psoriasis and type 2."

Similar presentations


Ads by Google